Antistaphylolysins are antibodies that are formed in the human body during staphylococcal infection. They are able to destroy staphylococcus bacteria, causing their lysis. This process can help treat staph infections and reduce the risk of complications.
Staphylococci are bacteria that can cause a variety of diseases, including infections of the skin, bones, joints and other organs. They can also cause food poisoning and other illnesses. Antistaphylolysins can help fight these bacteria, as they can destroy their cell wall and cause their death.
One way to obtain antistaphylolysins is to use staphylococcal toxin. This toxin is produced by staphylococci and can cause various diseases in humans. However, when antistaphylocollizin is administered, it can neutralize the effect of the toxin and prevent the development of diseases.
In addition, antistaphylococcal antibodies can be obtained from the blood plasma of people who have already had staphylococcal infections. This plasma contains antibodies that can destroy staphylococci. After receiving this plasma, patients may be protected from recurrent staph infections.
In general, antistaphylococcal therapy using antistaphylococcal antibodies is an effective way to combat staphylococcal infections and prevent the development of complications. However, before using these methods, it is necessary to conduct an examination and determine which antibodies are necessary for the treatment of a particular patient.
Antistaphylococcal antibodies are specific immunoglobulins (IgG) that react with components of staphylococcal antigens and cause lysis (dissolution) of microorganism colonies on nutrient media. Lysis is the result of the reaction of these antibodies with the surface structures of microorganisms and disabling them.
How does the mechanism of antistaphylococcal antibodies work? Proteins of antigenic epitopes of staphylococcal cell walls interact with specific receptors or “leucine receptors” of antistaphylococcal antibodies, which are located on the surface of immune cells. This binding triggers a cascade of further immune system responses, including the assembly of B cells, antibody presenting cells, and cytotoxic T lymphocytes (CTLs), which in turn destroy the infectious microorganisms. Ultimately, immunity is directed against staphylococcus aureus and other types of staphylococci, which prevents their spread within the body.
Antistaphylococcal protection is usually formed by the human immune system in response to infection